Analysis of research showing trace elements of antibacterial ingredients in pregnant women and fetuses is distorting the safety profile of the materials, which have been extensively researched and reviewed for decades, according to the American Cleaning Institute (ACI).
The research in question was presented at American Chemical Society national meeting and reported that trace elements of the antibacterial ingredients triclosan and triclocarban were detected in the urine of pregnant women, as well as some umbilical cord blood samples.
Some of the researchers’ public comments – and well as news media headlines about the research – may mislead the public about the ingredients’ safety, the association says.
“The levels of these ingredients they found are extremely small and are excreted from the body,” says Dr. Paul DeLeo, ACI associate vice president of environmental safety. “There’s a wide margin of safety between these levels and the levels deemed unsafe based on standard safety evaluation. The weight of evidence supports the conclusion that these ingredients are not causing adverse effects on the endocrine system. The continued ‘suggestions’ that the presence of these substances are leading to health risks are not borne out by the data and years of safe use by consumers.”
In comments submitted earlier this year to the Food and Drug Administration (FDA) on the safety of triclosan, ACI wrote: “Triclosan-containing consumer antiseptic wash products play a beneficial role in the daily hygiene routines of millions of people throughout the U.S. and worldwide. They have been and are used safely and effectively in homes, hospitals, schools and workplaces every single day. Furthermore, triclosan and products containing it are regulated by a number of governmental bodies around the world and have a long track record of human and environmental safety which is supported by a multitude of science-based, transparent risk analyses.”
Source: American Cleaning Institute (ACI)
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.